US 9895448
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
granted A61KA61K47/545A61K47/549
Quick answer
US patent 9895448 (Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Grant date
- Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K47/545, A61K47/549, A61K47/551, A61K47/554